Steglatro (Ertugliflozin) for Diabetes | DiabetesTeam

Connect with others who understand.

sign up log in
About DiabetesTeam
Powered By

Steglatro is a prescription drug approved by the Food and Drug Administration (FDA) to help improve blood glucose control in adults with type 2 diabetes. Steglatro is considered an adjunct treatment to diet and exercise. Steglatro is also referred to by its drug name, Ertugliflozin.

Steglatro is a sodium-glucose transporter 2 (SGLT2). Steglatro is believed to work by causing excess glucose to be eliminated in the urine.

How do I take it?
Prescribing information states that Steglatro is taken once daily in the morning, with or without food.

Steglatro comes in tablet form.

Side effects
The FDA-approved label for Steglatro lists yeast infections in women as a common side effect.

Rare but serious side effects listed for Steglatro include hypoglycemia (low blood glucose), kidney problems, and urinary tract infections.

For more details about this treatment, visit: – Merck

What Are My Options? – American Diabetes Association

Continue with Facebook
Continue with Google
Your privacy is our priority. By continuing, you accept our Terms of Use and Privacy Policy.
Already a Member? Log in